Direct mechanisms of sex hormone function on cancer cells have been extensively described in the context of hormone receptor‐positive (HR+) breast and prostate cancer (reviewed in 24, 78, and 79), and similar mechanisms likely impact HR+ growth in the brain (Figure 2A,B). This evidence concerns the gene NR4A1 and cancer.